On June 4, the FDA approved Emgality (galcanezumab-gnlm) solution for injection for the treatment of episodic cluster headache in adults.
Read more at fda.gov.
On June 4, the FDA approved Emgality (galcanezumab-gnlm) solution for injection for the treatment of episodic cluster headache in adults.
Read more at fda.gov.